These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20723657)

  • 1. Novel hypertrophic cardiomyopathy phenotype: segmental hypertrophy isolated to the posterobasal left ventricular free wall.
    Maron BJ; Sherrid MV; Haas TS; Lindberg J; Kitner C; Lesser JR
    Am J Cardiol; 2010 Sep; 106(5):750-2. PubMed ID: 20723657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.
    Klues HG; Schiffers A; Maron BJ
    J Am Coll Cardiol; 1995 Dec; 26(7):1699-708. PubMed ID: 7594106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.
    Chelliah RK; Senior R
    Future Cardiol; 2009 Sep; 5(5):495-502. PubMed ID: 19715413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy.
    Kelley-Hedgepeth A; Towbin JA; Maron MS
    Circulation; 2009 Jun; 119(23):e588-9. PubMed ID: 19528341
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe left ventricular wall thinning and extensive fibrosis without evolution to end stage disease in a patient with hypertrophic cardiomyopathy.
    Assenza GE; Spirito P; Musumeci MB; Lombardi M; Quarta G; Autore C
    J Am Soc Echocardiogr; 2009 Oct; 22(10):1196.e1-2. PubMed ID: 19801310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
    J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography.
    Caselli S; Pelliccia A; Maron M; Santini D; Puccio D; Marcantonio A; Pandian NG; De Castro S
    Am J Cardiol; 2008 Sep; 102(5):616-20. PubMed ID: 18721523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: report of 2 cases.
    Sato Y; Matsumoto N; Yoda S; Kunimasa T; Matsuo S; Komatsu S; Tani S; Kasamaki Y; Kunimoto S; Achenbach S; Saito S; Hirayama A
    Int J Cardiol; 2008 Oct; 129(3):e88-90. PubMed ID: 17888531
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging.
    Pons-Lladó G; Carreras F; Borrás X; Palmer J; Llauger J; Bayés de Luna A
    Am J Cardiol; 1997 Jun; 79(12):1651-6. PubMed ID: 9202357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular myocardial diastolic dysfunction in different kinds of cardiac hypertrophy: analysis by pulsed Doppler tissue imaging.
    Galderisi M; Severino S; Caso P; Cicala S; Petrocelli A; De Simone L; Mininni N; de Divitiis O
    Ital Heart J; 2001 Dec; 2(12):912-20. PubMed ID: 11838339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphologic aspects of the left ventricular remodeling in hypertensive cardiomyopathy].
    Mandarim-de-Lacerda CA
    Arq Bras Cardiol; 1995 Dec; 65(6):523-7. PubMed ID: 8731308
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential value of myocardial contrast echocardiography for the detection of myocardial fibrosis in hypertrophic cardiomyopathy.
    Chaudeurge A; Garçon P; Cador R
    Arch Cardiovasc Dis; 2011 Dec; 104(12):682-3. PubMed ID: 22152520
    [No Abstract]   [Full Text] [Related]  

  • 13. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography.
    Kato TS; Noda A; Izawa H; Yamada A; Obata K; Nagata K; Iwase M; Murohara T; Yokota M
    Circulation; 2004 Dec; 110(25):3808-14. PubMed ID: 15583080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated right ventricular infarction in a case of hypertrophic cardiomyopathy.
    Mittal SR; Babu D; Roy R
    Int J Cardiol; 1995 Aug; 51(1):98-9. PubMed ID: 8522404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Left ventricular rotation and twist in patients with hypertrophic cardiomyopathy evaluated by two-dimensional ultrasound speckle-tracking imaging].
    Xie MX; Zhang L; Lü Q; Wang XF; Han W; Zhang J; Liu YY; Fu Q; Xiang FX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):58-62. PubMed ID: 18361055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of right ventricle in left ventricular hypertrophic cardiomyopathy: analysis by pulsed Doppler tissue imaging.
    Severino S; Caso P; Cicala S; Galderisi M; de Simone L; D'Andrea A; D'Errico A; Mininni N
    Eur J Echocardiogr; 2000 Dec; 1(4):281-8. PubMed ID: 11916607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertrophic cardiomyopathy and physiologic hypertrophy in athletes: a new diagnostic approach using tissue color Doppler].
    Malergue MC
    Arch Mal Coeur Vaiss; 1999 Feb; 92(2):197-9. PubMed ID: 10078338
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy.
    Brown ML; Schaff HV; Dearani JA; Li Z; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):439-43. PubMed ID: 20832083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
    Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
    Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography.
    Sun JP; Stewart WJ; Yang XS; Donnell RO; Leon AR; Felner JM; Thomas JD; Merlino JD
    Am J Cardiol; 2009 Feb; 103(3):411-5. PubMed ID: 19166699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.